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BCL2 5'-CTGCGAAGAACCTTGTGTGA-3'
5'-TGTCCCTACCAACCAGAAGG-3'
CASP3 5'-CAGACGCGGCTCCTAGCGGAT-3'
5'-GGCTCGCTAACTCCTCACGGC-3'
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Fig. 1 The number of HUVECs was counted with a Burker-Turk counting chamber. HUVECs were incubated for 14 days and the 
following fresh media were added every 12 hours, respectively : 1 continuous 5 mmol/L glucose medium L Group , 
2 continuous 25 mmol/L glucose medium H Group , 3 alternating 5 mmol/L and 25 mmol glucose medium, and cells 
were harvested under conditions of high-glucose medium LH Group , and 4 alternating 5 mmol/L and 25 mmol glucose 
medium, and cells were harvested under conditions of low-glucose medium HL Group . There were no signi cant differ-
ences among the four groups after incubation for 14 days.
Fig. 2 Comparison of PTX3 protein expression in the supernatant of conditioned media after incubation for 14 days. The expres-
sion of PTX3 protein in the LH group was signi cantly higher than those in the L group p<0.05 and the HL group p<0.05 .
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Fig. 4 Comparison of PTX3 protein expression in HUVECs after incubation for 14 days. The expression of PTX3 protein in the 
LH group was signi cantly higher than those in the L group p<0.05 and the HL group p<0.05 .
Fig. 3 Expression levels of PTX3, BCL2, and CASP3 in HUVECs were measured by real-time PCR and normalized by the house-
keeping gene 18S rRNA. No signi cant differences among these four groups after incubation for 14 days were observed in 
terms of expression of PTX3, BCL2, and CASP3 mRNA.
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Fig. 5 Apoptosis were evaluated using the TUNEL method. Nuclei were stained with blue upper left panel , TUNEL-positive 
cells apoptotic cells were stained with green upper right . Phase-contrast views bottom left and merged DAPI and 
TUNEL positive cells bottom right . TUNEL positive cells were detected in all groups.  However, TUNEL positive cells 
were signi cantly higher in the HL group compared with the other groups, and also signi cantly higher in the H group than 
the L group and the LH group.
Fig. 6 Caspase 3/7 activity in HUVECs was measured by a Luminometer and normalized by the L group. There were no signi -
cant differences among the four groups after incubation for 14 days.  
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Abstract
  Background Pentraxin 3 PTX3 is an acute-phase protein, and it is expressed not only in vascular endothelial and 
smooth muscle cells, but also in atherosclerotic lesions. The aim of this study was to explore whether glucose spikes induce 
PTX3 expression in vascular endothelial cells.
  Methods Cultured human umbilical vein endothelial cells HUVECs were divided into four groups described in the 
legend to Fig. 1. Supernatants and HUVECs were collected from each culture plate after 14 days of incubation to measure the 
concentration of PTX3 protein production and to evaluate gene expressions and protein expressions. We also evaluated the 
proportion of apoptotic cells after 14 days of treatment.
  Results Compared with the L group or the HL group the
LH group p<0.05
the 4 groups. Compared with the L group or the HL group
LH group p<0.05
groups. 
  Conclusion Glucose spike-induced PTX3 production from HUVECs as the glucose concentration increased in the culture 
medium. On the other hand, more apoptotic cells were observed according as the glucose concentration decreased in the cul-
ture medium compared with the other conditions. These results suggest that elevation and reduction in glucose levels exert dif-
ferent effects on vascular endothelial cells.
Key words :  Normal human umbilical vein endothelial cells HUVECs , Glucose uctuation, Pentraxin 3 PTX3 , Apopto-
sis
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